Author:
Sunn Shelareen Ediemi,Pakyntein Careen Liza,Thabah Daiahun,Kharshiing Cynthia Erica,Banerjee Sagnik,Rai Anita Kumari,Bhattacharjee Atanu,Syiem Donkupar
Abstract
Abstract
Background
Potentilla fulgens Wall. ex Sims. is a medicinal plant used by the locals of Meghalaya. However, its mechanism of action has not been well elucidated. Hence, this study investigated the effect of P. fulgens on IRS1 and Akt. The interaction of the various polyphenols present in P. fulgens with the IR tyrosine kinase and IRS1 PTB domain was studied using auto dock. Changes in expression of antioxidant enzymes, IRS-1, Akt and behavior of normal, diabetic, and diabetic mice treated mice were assessed after 14 days of treatment. Morphological changes in the liver tissue were determined by Transmission Electron Microscopy.
Results
The effect of P. fulgens on blood glucose was time and dose dependent. Treatment with P. fulgens, Cat, E, CE, CEP and metformin improved the activity of catalase, glutathione peroxidase, glycogen, IRS-1 and Akt. The Forced Swimming test showed an altered behavior in diabetic mice. The altered mobility was reverted back to near normal on treatment with P.fulgens, Cat, E, CE, CEP and metformin. The morphological aberrations seen in diabetic animals considerably improved in the treated diabetic group.
Conclusion
P. fulgens and its phytochemicals-catechin and epicatechin are potent sources of antidiabetic drugs, possibly mediating their effects through upregulation of insulin IRS-1 and Akt.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Magliano DJ, Boyko EJ. IDF Diabetes Atlas. 10th ed. Brussels: Belgium; 2021.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35:S64–70. https://doi.org/10.2337/dc10-S062.
3. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest. 1981;68(4):957–69. https://doi.org/10.1172/jci110350.
4. de Meyts P. The insulin receptor and its signal transduction Network. In: Feingold KR, Anawalt B, Blackman MR(ed).SouthDartmouth (MA): MDText.com, Inc. 2016; https://www.ncbi.nlm.nih.gov/books/NBK378978/.
5. Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring HarbPerspect Biol. 2016;6(1):a009191.